PE20020393A1 - Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados - Google Patents

Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados

Info

Publication number
PE20020393A1
PE20020393A1 PE2001000853A PE2001000853A PE20020393A1 PE 20020393 A1 PE20020393 A1 PE 20020393A1 PE 2001000853 A PE2001000853 A PE 2001000853A PE 2001000853 A PE2001000853 A PE 2001000853A PE 20020393 A1 PE20020393 A1 PE 20020393A1
Authority
PE
Peru
Prior art keywords
alkyl
aryl
formula
heterocycle
halo
Prior art date
Application number
PE2001000853A
Other languages
English (en)
Inventor
Michael Huai Gu Chen
Edward Mark Davis
Derick Dale Winkle
Thomas Norman Nanninga
Javier Magano
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PE20020393A1 publication Critical patent/PE20020393A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE REFIERE A UN PROCESO PARA SINTETIZAR COMPUESTOS ACIDOS N-ARILANTRANILICOS DE FORMULA I DONDE R1 ES H, ALQUILO, ALCOXI, ARILO; R2, R3, R4, R5, R6, R7, R8, R9, R10 SON H, HALO, ALQUILO, ARILO, HETEROCICLO, HALOALQUILO, ALCOXI, NITRO, (O)m-(CH2)nR11; m ES 0-1; n ES 0-4; R11 ES H, OH, CO2H, N(R12)R13; R8, R9, R10 JUNTOS FORMAN ARILO, HETEROARILO, HETEROCICLO, CICLOALQUILO, R1 Y R6 JUNTO A N Y R1 FORMAN UN ANILLO DIHIDROAROMATICO DE 5-6 MIEMBROS; R12 Y R13 SON H, ALQUILO; O JUNTO A N FORMAN UN HETEROCICLO DE 3-10 MIEMBROS; Z ES COOH, COOM, COOR15, CONR16R17; M ES UN CATION DE METAL; R15 ES ALQUILO, ALQUENILO, ENTRE OTROS; R16, R17, R18, R19 SON H, ALQUILO, ALQUENILO, FENILO, BENCILO; QUE COMPRENDE REACCIONAR UN COMPUESTO FENILAMINO SUSTITUIDO DE FORMULA A CON UN ARILO SUSTITUIDO DE FORMULA B; X ES HALO, O-LG; LG ES SO2R20, PO(OR20)2; R20 ES ALQUILO, ARILO EN PRESENCIA DE UN SOLVENTE COMO ACETONITRILO, TETRAHIDROFURANO, 1,2-DIETOXIETANO, ETER DIETILICO, ENTRE OTROS; UNA BASE COMO HIDRURO, DIALQUILAMIDA, DIISOPROPILAMIDA, ALCOXIDO; INICIALMENTE SE UTILIZA DE 1-5 EQUIVALENTES Y OPTATIVAMENTE SE AGREGAN DE 0,5 A 4 EQUIVALENTES AGREGANDOSE EN INTERVALOS POR UN TIEMPO Y A UNA TEMPERATURA DE -78°C A 150°C. EL PROCEDIMIENTO PUEDE OBTENER RENDIMIENTOS MAS ALTOS Y MINIMIZAR LA CANTIDAD DE ANILINA REQUERIDA
PE2001000853A 2000-08-25 2001-08-24 Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados PE20020393A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22820600P 2000-08-25 2000-08-25

Publications (1)

Publication Number Publication Date
PE20020393A1 true PE20020393A1 (es) 2002-05-09

Family

ID=22856235

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000853A PE20020393A1 (es) 2000-08-25 2001-08-24 Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados

Country Status (31)

Country Link
EP (1) EP1313694A1 (es)
JP (1) JP2004507518A (es)
KR (1) KR20030059115A (es)
CN (1) CN1458921A (es)
AP (1) AP2001002249A0 (es)
AR (1) AR032175A1 (es)
AU (1) AU2001277044A1 (es)
BG (1) BG107635A (es)
BR (1) BR0113520A (es)
CA (1) CA2420003A1 (es)
CZ (1) CZ2003477A3 (es)
DO (1) DOP2001000238A (es)
EA (1) EA200300187A1 (es)
GT (1) GT200100174A (es)
HN (1) HN2001000216A (es)
HU (1) HUP0300828A2 (es)
IL (1) IL154507A0 (es)
IS (1) IS6724A (es)
MA (1) MA26949A1 (es)
MX (1) MXPA03001654A (es)
NO (1) NO20030844L (es)
PA (1) PA8526501A1 (es)
PE (1) PE20020393A1 (es)
PL (1) PL360699A1 (es)
SK (1) SK2072003A3 (es)
SV (1) SV2002000601A (es)
TN (1) TNSN01127A1 (es)
UY (1) UY26908A1 (es)
WO (1) WO2002018319A1 (es)
YU (1) YU14303A (es)
ZA (1) ZA200301182B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI338685B (en) 2002-03-13 2011-03-11 Array Biopharma Inc N3 alkylated benzimid azole derivatives as mek inhibitors
US7235537B2 (en) 2002-03-13 2007-06-26 Array Biopharma, Inc. N3 alkylated benzimidazole derivatives as MEK inhibitors
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7538120B2 (en) 2003-09-03 2009-05-26 Array Biopharma Inc. Method of treating inflammatory diseases
EP1682495A1 (en) 2003-10-21 2006-07-26 Warner-Lambert Company LLC Polymorphic form of n- (r)-2,3-dihydroxy-propoxy -3,4-d ifluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
WO2005051300A2 (en) 2003-11-19 2005-06-09 Array Biopharma Inc. Bicyclic inhibitors of mek and methods of use thereof
US7517994B2 (en) 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7732616B2 (en) 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
KR20110137838A (ko) 2003-11-21 2011-12-23 어레이 바이오파마 인크. Ａｋｔ 단백질 키나제 억제제
UA89035C2 (ru) 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
RS52715B (en) 2005-04-13 2013-08-30 Astex Therapeutics Limited HYDROXYBENZAMIDE DERIVATIVES AND THEIR APPLICATIONS AS HSP90 INHIBITORS
ATE539064T1 (de) 2005-05-18 2012-01-15 Array Biopharma Inc Heterozyklische inhibitoren von mek und verwendungsverfahren damit
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
JP5268904B2 (ja) 2006-07-06 2013-08-21 アレイ バイオファーマ、インコーポレイテッド Ａｋｔプロテインキナーゼ阻害剤としてのシクロペンタ［ｄ］ピリミジン
ATE493418T1 (de) 2006-07-06 2011-01-15 Array Biopharma Inc Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren
SI2054418T1 (sl) 2006-07-06 2012-02-29 Array Biopharma Inc Dihidrotieno pirimidini kot AKT protein kinazni inhibitorji
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
EP2081891A2 (en) 2006-10-12 2009-07-29 Astex Therapeutics Limited Pharmaceutical compounds having hsp90 inhibitory or modulating activity
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
EP2073802A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
JP5518478B2 (ja) 2006-10-12 2014-06-11 アステックス、セラピューティックス、リミテッド 医薬化合物
MX2009014013A (es) 2007-07-05 2010-01-28 Array Biopharma Inc Pirimidil ciclopentanos como inhibidores de la proteina cinasa akt.
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
RU2486181C2 (ru) 2007-07-05 2013-06-27 Эррэй Биофарма Инк. Пиримидилциклопентаны как ингибиторы акт-протеинкиназ
MX2010007546A (es) 2008-01-09 2010-09-30 Array Biopharma Inc Pirimidil ciclopentanos hidroxilados en forma de inhibidores de akt proteína quinasa.
JP5346345B2 (ja) 2008-01-09 2013-11-20 アレイ バイオファーマ、インコーポレイテッド Ａｋｔタンパク質キナーゼ阻害剤としての水酸化されたピリミジルシクロペンタン類
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
CN101985428B (zh) * 2009-07-29 2014-02-12 杭州民生药业有限公司 邻苯胺基苯甲酸衍生物或其药学上可接受的盐、其制备方法及其用途
WO2011101604A1 (fr) * 2010-02-19 2011-08-25 Centre National De La Recherche Scientifique Procede de preparation de composes chimiques d'interet par substitution nucleophile aromatique de derives d'acides carboxyliques aromatiques portant au moins un groupement electroattracteur
CN102958892A (zh) * 2010-02-19 2013-03-06 国家科学研究中心 通过芳香族亲核取代来制备目的化合物的方法
ES2688809T3 (es) 2011-04-01 2018-11-07 Genentech, Inc. Combinaciones de compuestos inhibidores de AKT y MEK para tratar el cáncer
ES2657750T3 (es) 2011-04-01 2018-03-06 Genentech, Inc. Combinación de compuesto inhibidor de AKT y vemurafenib para su uso en tratamientos terapéuticos
PL2909188T3 (pl) * 2012-10-12 2018-08-31 Exelixis, Inc. Nowy sposób wytwarzania związków do stosowania w leczeniu raka
CN112745237B (zh) * 2019-10-29 2023-06-20 中国科学院上海药物研究所 2-芳基胺类化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138636A (en) * 1960-06-23 1964-06-23 Parke Davis & Co Anthranilic acid derivatives
WO1998037881A1 (en) * 1997-02-28 1998-09-03 Warner Lambert Company Method of treating or preventing septic shock by administering a mek inhibitor
CN1163475C (zh) * 1997-07-01 2004-08-25 沃尼尔·朗伯公司 4-溴或4-碘苯基氨基苯氧肟酸衍生物及其作为mek抑制剂的用途
NZ501277A (en) * 1997-07-01 2002-12-20 Warner Lambert Co -2(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
CA2348236A1 (en) * 1999-01-13 2000-07-20 Stephen Douglas Barrett 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
ES2235843T3 (es) * 1999-04-21 2005-07-16 Warner-Lambert Company Llc Metodo para la produccion de acidos 2-(n-fenilamino)benzoicos.

Also Published As

Publication number Publication date
KR20030059115A (ko) 2003-07-07
IL154507A0 (en) 2003-09-17
BR0113520A (pt) 2003-06-24
SK2072003A3 (en) 2004-01-08
AU2001277044A1 (en) 2002-03-13
CN1458921A (zh) 2003-11-26
GT200100174A (es) 2002-07-18
JP2004507518A (ja) 2004-03-11
PL360699A1 (en) 2004-09-20
HN2001000216A (es) 2002-05-22
HUP0300828A2 (hu) 2003-09-29
SV2002000601A (es) 2002-04-03
IS6724A (is) 2003-02-20
PA8526501A1 (es) 2002-07-30
AR032175A1 (es) 2003-10-29
EA200300187A1 (ru) 2003-08-28
ZA200301182B (en) 2004-05-12
YU14303A (sh) 2006-08-17
UY26908A1 (es) 2001-11-30
DOP2001000238A (es) 2003-01-31
BG107635A (bg) 2004-09-30
WO2002018319A1 (en) 2002-03-07
AP2001002249A0 (en) 2001-09-30
MXPA03001654A (es) 2004-09-10
CZ2003477A3 (cs) 2003-10-15
NO20030844D0 (no) 2003-02-24
TNSN01127A1 (en) 2005-11-10
NO20030844L (no) 2003-02-25
CA2420003A1 (en) 2002-03-07
MA26949A1 (fr) 2004-12-20
EP1313694A1 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
PE20020393A1 (es) Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados
DK633088A (da) Kollagenaseinhibitorer
DK116480A (da) Fremgangsmaade til fremstilling af substituerede chromoner
FR2398718A1 (fr) Nouvelles amines primaires utiles a la preparation de derives d'aminoalkyl benzenes
PE20000119A1 (es) Nuevos derivados de la eritromicina
ES2036852T3 (es) Procedimiento para la obtencion de trifluormetilfenil-azolilmetiloxiranos y su empleo como agentes protectores de las plantas.
SE8106125L (sv) 4,5-polymetylen-4-isotiazolin-3-oner, sett for framstellning derav och anvendning derav som baktericida och fungicida medel
ES2528716T3 (es) Procedimiento para la preparación de derivados de piridina
PE20050160A1 (es) 3-aminopirrolidinas como inhibidores de la captacion de monoaminas
PE10597A1 (es) 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas
AR036176A1 (es) Un derivado de fenil-acetamido-tiazol, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un producto o kit que los comprende, y un metodo que utiliza dicho derivado
ES2058531T3 (es) Amidas de mercapto-fenilalcanoilaminoacidos, su preparacion y su uso como inhibidores de colagenasa.
AR046041A1 (es) Procedimiento para la preparacion de compuestos heterociclicos n-amino sustituidos
RU2010104475A (ru) Аминоацильные пролекарства в качестве фармацевтически действующих веществ для лечения тромбоэмболических заболеваний
US3905997A (en) 3-Aryl-5-oxo-2-pyrazoline-4-carboxanilides and process therefor
PE20030929A1 (es) Acidos 3-(imidazolil)-2-alcoxipropanoicos
SE7904595L (sv) Nya optiskt aktiva oxazafosforinderivat och forfarande for framstellning derav
ES390163A1 (es) Procedimiento para la preparacion de amino-derivados de los acidos pirazolo (3,4-b) piridina-5-carboxilicos.
ES446694A1 (es) Procedimiento para la preparacion de nuevos acidos 3-(4-bi- fenilil)-butiricos, sus esteres y amidas.
ES2273619T1 (es) Procedimiento de preparacion de derivados de feniltetrazol.
ES2130181T3 (es) Composicion para el control de plantas y metodos de uso.
ES378202A1 (es) Procedimiento para la preparacion de nuevos 2-amino-5-ni- trotiazoles sustituidos en el grupo amino.
KR960703126A (ko) 5-ht1a_1a 리간드로서의 아베오-에르골린 유도체(abeo-ergoline derivatives as 5ht1a ligands)
ECSP034536A (es) Derivados de acido propionico
MX9400150A (es) Procedimiento para la preparacion de eteres de hidroxilamina, asi como sus sales y los productos intermedios que se utilizan para ese fin.

Legal Events

Date Code Title Description
FC Refusal